PUK3 Sources of Heterogeneity Among Overactive Bladder Clinical Trial Estimates of Tolterodine and Fesoterodine Reductions of Urgency Urinary Incontinence Episodes Relative to Placebo
Nov 1, 2011, 00:00 AM
10.1016/j.jval.2011.08.538
https://www.valueinhealthjournal.com/article/S1098-3015(11)02100-0/fulltext
Section Title :
Urinary/Kidney Disorders
Section Order :
505
First Page :
A330
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)02100-0&doi=10.1016/j.jval.2011.08.538